SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001387131-19-006893
Filing Date
2019-09-12
Accepted
2019-09-12 07:31:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS tnxp-424b3_091119.htm 424B3 240744
2 GRAPHIC tnxp-s1a001.jpg GRAPHIC 5241
3 GRAPHIC tnxp-s1a002.jpg GRAPHIC 5241
  Complete submission text file 0001387131-19-006893.txt   256541
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-233445 | Film No.: 191089526
SIC: 2834 Pharmaceutical Preparations